Gland Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has submitted to NSE a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This is a routine annual compliance filing where promoters of listed companies report their shareholding details and any encumbrance positions. The announcement does not include any specific numbers, changes in promoter stake, or pledge-related details beyond confirming that the disclosure has been filed.
This is a routine regulatory filing with no immediate material impact on shareholders or stock price. Investors should wait for the actual disclosure contents to be reviewed for any meaningful changes in promoter holding or encumbrances.